Eco Animal Health Share Discussion Threads

[cerrito] 08/9/2022 08:44

Interested to reads this guarded optimism from Genus in their results RNS this morning
quote
Over the summer, China's live pig prices have risen above 21 RMB/kg, improving confidence that the country's porcine industry is on the path to recovery and profitability. Industry expectations are that prices will continue to exceed 20 RMB/kg for the remainder of 2022, although there could still be some further volatility.
unquote

[waldron] 05/9/2022 16:48

5 September 2022

ECO Animal Health Group plc

("ECO" or "the Group")

(AIM: EAH)

Investor Presentation covering Full Year Results

ECO Animal Health Group plc ("ECO" or "the Group"), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, is pleased to announce that David Hallas, CEO, and Christopher Wilks, CFO, will be conducting a live presentation covering the Group's Full Year Results for the period ended 31 March 2022.

The online presentation will take place on Wednesday 7 September at 10.00am UK time. This event is open to all existing and potential shareholders and registration is free. Questions can be submitted during the presentation and will be addressed at the end of it.

[cerrito] 05/9/2022 10:58

an article going through what Xi Jinping sees as the need to keep China's rice bowl steady ie get food self sufficiency which for me is why the interests oif EAH andf the CCP are aligned.

[smithless] 31/8/2022 11:29

Well if someone going to bid for EAH this is the time to do it. Lowest its been since 2008. 200p bid may just do it.

[sarkasm] 23/8/2022 12:38

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, today announces a revised date for the publication of its preliminary results for the year ended 31 March 2022.

The Company's auditor, BDO LLP, has requested additional time to complete its audit completion procedures. As a result, the Company now expects to announce its final results on 31 August 2022.

[cerrito] 23/8/2022 12:16

As both the pound and the share price gently slide down people must be looking at this ref an acquisition.
I wonder how much relations with China are affecting this. Cannot help but the interests of EAH and the CCP are well aligned.

[smithless] 23/8/2022 11:28

I know the management have a habit of finding every banana skin to slip on, but a market cap of £63m seem too low. For a large pharma company in this space, just by stripping out overheads and using their distribution scale it would make this a very profitable acquisition!

[buywell3] 11/8/2022 07:43

free stock charts from uk.advfn.com

[edmonda] 10/8/2022 14:15

As you say, results are now keenly awaited . Ahead of that, short note on the TU and financial news out from Equity Dev. Also notes that valuation ratings starting to look low in the sector after steady share price falls. Free access here:

[cerrito] 09/8/2022 08:32

Rivaldo you are smarter than me by avoiding this share. My book loss is comfortably the largest of my holdings.
Will be interesting to see what Singer says when the results come out.
Note that a long standing NED resigns with immediate effect.

[la forge] 08/8/2022 16:20

Consensus


Mean consensus BUY


Number of Analysts 3

Last Close Price 127,50 GBX

Average target price 271,33 GBX
Spread / Average Target 113%

High Price Target 350,00 GBX
Spread / Highest target 175%

Low Price Target 200,00 GBX
Spread / Lowest Target 56,9%


marketscreener.com - S&P Global Market Intelligence

[tradertrev] 08/8/2022 16:08

Good point fastbuck - hands up who thinks the analysts will forecast the improved trading conditions before they actually happen?!

[fastbuck] 08/8/2022 15:05

I think you need to play the Chinese demand, once it's in the broker forecasts the share price will be up significantly, buy whilst the broker estimates are on the floor and hog prices are climbing. Remember that they still have strong demand from ROW and R and D efforts are moving in right direction creating new products. Whilst some heavy weight investors still on the share register, I understand, whilst trading at below net tangible assets

[rivaldo] 08/8/2022 14:00

Not a holder here, but a (very!) long-term observer with EAH never having moved from watchlist to actual portfolio.

Had to comment on an earlier post that today's update was in line. Singer have issued an update note stating that the actual £6.5m EBITDA compares to their £7.1m forecast, so is quite a large miss.

They'll update all forecasts after the results, but the historic number will now evidently be lower than the previously forecast 2p EPS. Their "initial stab" for the current year suggests in light of the "soft start" to the year in China that "a flat year is in prospect", suggesting that EPS to March'23 will also be recalculated down to say 1.8p EPS or so.

[aimingupward2] 08/8/2022 11:16

Reminder: on 12th May the CEO bought 33K shares at 117p. He must have had a realistic assessment of the the situation and future prospects, so it’s reasonable to judge any price lower than this to be very good value.

[tradertrev] 08/8/2022 10:50

Think that's a bit harsh. His first 18 months was spent chasing down earlier accounting errors and re-jigging the previous 10 years' accounts. There has also been massive restriction on international travel to enable "whites of the eyes" interrogation of local accounting staff.
An R&D change in accounting can happen at any time to any company.
Then there is the small matter of the substantial investment Mr Wilks has made in the shares - something woefully missing with many other AIM companies.
He still has my confidence and I have made a small top up investment this morning.

[cerrito] 08/8/2022 10:22

I repeat a comment that I have made before namely that s company with three joint brokers( and why they need 3 brokers would be a good question for their next IMC type event) produces a RNS which you need to read 2/3 times to get a sense of what is going on.
In terms of the tax, my first reaction was what a load of accident prone plonkers. I can understand why they did not want to explicitly name the country and if it is one with many confusing tax regulations like Brazil I would be prepared to cut them some slack. That and the R&D issue suggests that the Finance area lacks grip, despite the quote new unquote FD being in post since August 2019.
My reading is that H2 sales 21/22 were £44m down from £64m for H2 2020/21. Nice to see strong non China sales in Q1 of this FY and and thus a more balanced geographic spread of sales.
My reading of the share price fall is that it is not driven by trading per se but rather lack of credibility in the Finance function.

[fastbuck] 08/8/2022 09:29

I actually take it that the 6.5m EBITDA (which was in line with the 6-7m forecast) was after the 1m CY charge for import tax which was coded to Cost of Sales, and R&D which was coded to overheads. Actually I think they were indicating that the results were a slight beat when factoring in these numbers without being too clear

[edmonda] 08/8/2022 08:30

Yes , encouraging news is re current FY after the charges re past year.

FY results due out c. 18 August, and co says that y/e to 31 March should see revs £82m< and EBITDA c. £6.5m. Its making £2.5m sales tax provision, and £0.3m adj re capitalised costs.

Q1 new FY saw strong gross margins in China + improvement in pork pricing.

[fastbuck] 08/8/2022 08:15

In line with broker note. Not sure what the fuss is, more importantly we are seeing recovery in China which is a positive, and strength elsewhere.

[tradertrev] 08/8/2022 07:48

Not sure this was the update we wanted.

[aimingupward2] 22/7/2022 16:41

Nevertheless/whatever, there has been steady buying all day today and the price has moved up with it.